EVH
Income statement / Annual
Last year (2025), Evolent Health Inc's total revenue was $1.88 B,
a decrease of 26.56% from the previous year.
In 2025, Evolent Health Inc's net income was -$534.51 M.
See Evolent Health Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$1.88 B |
$2.55 B |
$1.96 B |
$1.35 B |
$907.96 M |
$924.64 M |
$687.12 M |
$627.06 M |
$434.95 M |
$254.19 M |
| Cost of Revenue |
$1.59 B
|
$2.19 B
|
$1.50 B
|
$1.04 B
|
$657.55 M
|
$696.58 M
|
$513.03 M
|
$327.83 M
|
$269.35 M
|
$155.18 M
|
| Gross Profit |
$283.03 M
|
$367.35 M
|
$460.47 M
|
$316.58 M
|
$250.41 M
|
$228.06 M
|
$174.09 M
|
$299.24 M
|
$165.60 M
|
$99.01 M
|
| Gross Profit Ratio |
0.15
|
0.14
|
0.23
|
0.23
|
0.28
|
0.25
|
0.25
|
0.48
|
0.38
|
0.39
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$27.00 M
|
$0.00
|
$0.00
|
$0.00
|
$18.20 M
|
$17.20 M
|
$11.10 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$219.50 M
|
$310.55 M
|
$392.82 M
|
$306.31 M
|
$205.67 M
|
$160.69 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$100.14 M
|
-$156.37 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$303.87 M
|
$263.05 M
|
$358.11 M
|
$269.27 M
|
$219.50 M
|
$210.41 M
|
$236.45 M
|
$306.31 M
|
$205.67 M
|
$160.69 M
|
| Other Expenses |
-$16.40 M
|
$144.79 M
|
$173.57 M
|
$16.67 M
|
$73.32 M
|
$280.49 M
|
$246.53 M
|
$109.00 K
|
$171.00 K
|
$4.00 K
|
| Operating Expenses |
$287.47 M
|
$407.84 M
|
$531.68 M
|
$312.94 M
|
$292.82 M
|
$490.91 M
|
$482.97 M
|
$350.82 M
|
$238.04 M
|
$177.92 M
|
| Cost And Expenses |
$1.88 B
|
$2.60 B
|
$2.04 B
|
$1.35 B
|
$950.37 M
|
$1.19 B
|
$996.01 M
|
$678.65 M
|
$507.39 M
|
$333.09 M
|
| Interest Income |
$4.19 M
|
$5.54 M
|
$5.26 M
|
$1.37 M
|
$407.00 K
|
$2.63 M
|
$3.41 M
|
$3.44 M
|
$1.66 M
|
$0.00
|
| Interest Expense |
$57.47 M
|
$24.72 M
|
$54.21 M
|
$15.57 M
|
$25.43 M
|
$28.33 M
|
$14.56 M
|
$5.48 M
|
$3.64 M
|
$723.00 K
|
| Depreciation & Amortization |
$115.85 M
|
$123.17 M
|
$123.42 M
|
$90.25 M
|
$60.04 M
|
$61.48 M
|
$60.91 M
|
$44.52 M
|
$32.37 M
|
$17.22 M
|
| EBITDA |
-$361.31 M |
$84.85 M |
-$24.79 M |
$43.75 M |
$55.66 M |
-$240.74 M |
-$254.52 M |
-$4.15 M |
-$40.40 M |
-$220.31 M |
| EBITDA Ratio |
-0.19
|
0.03
|
-0.01
|
0.03
|
0.06
|
-0.26
|
-0.37
|
-0.01
|
-0.09
|
-0.87
|
| Operating Income Ratio |
-0
|
-0.02
|
-0.04
|
0
|
-0.05
|
-0.28
|
-0.45
|
-0.08
|
-0.17
|
-0.93
|
| Total Other Income/Expenses Net |
-$530.20 M
|
-$22.55 M
|
-$131.19 M
|
-$65.72 M
|
$12.61 M
|
-$67.69 M
|
-$21.10 M
|
-$6.67 M
|
-$3.56 M
|
-$114.00 K
|
| Income Before Tax |
-$534.64 M
|
-$63.04 M
|
-$202.41 M
|
-$62.08 M
|
-$29.80 M
|
-$330.54 M
|
-$329.99 M
|
-$54.15 M
|
-$76.40 M
|
-$237.53 M
|
| Income Before Tax Ratio |
-0.28
|
-0.02
|
-0.1
|
-0.05
|
-0.03
|
-0.36
|
-0.48
|
-0.09
|
-0.18
|
-0.93
|
| Income Tax Expense |
-$126.00 K
|
-$1.41 M
|
-$89.37 M
|
-$43.38 M
|
$483.00 K
|
-$2.37 M
|
-$22.80 M
|
$40.00 K
|
-$6.64 M
|
-$10.76 M
|
| Net Income |
-$534.51 M
|
-$61.62 M
|
-$113.04 M
|
-$19.16 M
|
-$37.60 M
|
-$334.25 M
|
-$301.97 M
|
-$52.66 M
|
-$60.67 M
|
-$159.74 M
|
| Net Income Ratio |
-0.28
|
-0.02
|
-0.06
|
-0.01
|
-0.04
|
-0.36
|
-0.44
|
-0.08
|
-0.14
|
-0.63
|
| EPS |
-5.07 |
-0.81 |
-1.28 |
-0.2 |
-0.36 |
-3.94 |
-3.71 |
-0.68 |
-0.94 |
-3.55 |
| EPS Diluted |
-5.07 |
-0.81 |
-1.28 |
-0.2 |
-0.36 |
-3.94 |
-3.71 |
-0.68 |
-0.94 |
-3.55 |
| Weighted Average Shares Out |
$114.21 M
|
$114.68 M
|
$111.25 M
|
$93.70 M
|
$86.07 M
|
$84.93 M
|
$82.36 M
|
$77.34 M
|
$64.35 M
|
$45.00 M
|
| Weighted Average Shares Out Diluted |
$114.21 M
|
$114.68 M
|
$111.25 M
|
$93.70 M
|
$86.07 M
|
$84.93 M
|
$82.36 M
|
$77.34 M
|
$64.35 M
|
$45.03 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
